266 related articles for article (PubMed ID: 36917668)
21. Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-β Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation.
Meyers JM; Uberoi A; Grace M; Lambert PF; Munger K
PLoS Pathog; 2017 Jan; 13(1):e1006171. PubMed ID: 28107544
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of Cellular MEK/ERK Signaling Suppresses Murine Papillomavirus Type 1 Replicative Activities and Promotes Tumor Regression.
Luna AJ; Young JM; Sterk RT; Bondu V; Schultz FA; Kusewitt DF; Kang H; Ozbun MA
bioRxiv; 2023 Apr; ():. PubMed ID: 36993217
[TBL] [Abstract][Full Text] [Related]
23. The environmental pollutant and tobacco smoke constituent dibenzo[def,p]chrysene is a co-factor for malignant progression of mouse oral papillomavirus infections.
Christensen ND; Chen KM; Hu J; Stairs DB; Sun YW; Aliaga C; Balogh KK; Atkins H; Shearer D; Li J; Brendle SA; Gowda K; Amin S; Walter V; Viscidi R; El-Bayoumy K
Chem Biol Interact; 2021 Jan; 333():109321. PubMed ID: 33186600
[TBL] [Abstract][Full Text] [Related]
24. Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).
Uberoi A; Yoshida S; Lambert PF
J Virol Methods; 2018 Mar; 253():11-17. PubMed ID: 29253496
[TBL] [Abstract][Full Text] [Related]
25. Immune Responses in Oral Papillomavirus Clearance in the MmuPV1 Mouse Model.
Brendle SA; Li JJ; Walter V; Schell TD; Kozak M; Balogh KK; Lu S; Christensen ND; Zhu Y; El-Bayoumy K; Hu J
Pathogens; 2023 Dec; 12(12):. PubMed ID: 38133335
[TBL] [Abstract][Full Text] [Related]
26. Passive Immunization with a Single Monoclonal Neutralizing Antibody Protects against Cutaneous and Mucosal Mouse Papillomavirus Infections.
Brendle SA; Li J; Cladel NM; Balogh KK; Booth J; Shearer DA; Walter V; Lu S; Christensen ND; Covington D; DeBroff J; Milici J; Zhu Y; Viscidi R; Hu J
J Virol; 2022 Aug; 96(16):e0070322. PubMed ID: 35920658
[TBL] [Abstract][Full Text] [Related]
27. A novel lineage-tracing mouse model for studying early MmuPV1 infections.
Yilmaz V; Louca P; Potamiti L; Panayiotidis M; Strati K
Elife; 2022 May; 11():. PubMed ID: 35533001
[TBL] [Abstract][Full Text] [Related]
28. Expanded Basal Compartment and Disrupted Barrier in Vocal Fold Epithelium Infected with Mouse Papillomavirus MmuPV1.
King RE; Ward-Shaw ET; Hu R; Lambert PF; Thibeault SL
Viruses; 2022 May; 14(5):. PubMed ID: 35632798
[TBL] [Abstract][Full Text] [Related]
29. Mus musculus papillomavirus 1 is a key driver of skin cancer development upon immunosuppression.
Dorfer S; Strasser K; Schröckenfuchs G; Bonelli M; Bauer W; Kittler H; Cataisson C; Fischer MB; Lichtenberger BM; Handisurya A
Am J Transplant; 2021 Feb; 21(2):525-539. PubMed ID: 33063442
[TBL] [Abstract][Full Text] [Related]
30. Role of IQGAP1 in Papillomavirus-Associated Head and Neck Tumorigenesis.
Wei T; Choi S; Buehler D; Lee D; Ward-Shaw E; Anderson RA; Lambert PF
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34068608
[TBL] [Abstract][Full Text] [Related]
31. Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model.
Tewari KS; Taylor JA; Liao SY; DiSaia PJ; Burger RA; Monk BJ; Hughes CC; Villarreal LP
Gynecol Oncol; 2000 Apr; 77(1):137-48. PubMed ID: 10739703
[TBL] [Abstract][Full Text] [Related]
32. Stress Keratin 17 Expression in Head and Neck Cancer Contributes to Immune Evasion and Resistance to Immune-Checkpoint Blockade.
Wang W; Lozar T; Golfinos AE; Lee D; Gronski E; Ward-Shaw E; Hayes M; Bruce JY; Kimple RJ; Hu R; Harari PM; Xu J; Keske A; Sondel PM; Fitzpatrick MB; Dinh HQ; Lambert PF
Clin Cancer Res; 2022 Jul; 28(13):2953-2968. PubMed ID: 35621713
[TBL] [Abstract][Full Text] [Related]
33. Loss of Keratin 17 induces tissue-specific cytokine polarization and cellular differentiation in HPV16-driven cervical tumorigenesis in vivo.
Hobbs RP; Batazzi AS; Han MC; Coulombe PA
Oncogene; 2016 Oct; 35(43):5653-5662. PubMed ID: 27065324
[TBL] [Abstract][Full Text] [Related]
34. The Mouse Papillomavirus Infection Model.
Hu J; Cladel NM; Budgeon LR; Balogh KK; Christensen ND
Viruses; 2017 Aug; 9(9):. PubMed ID: 28867783
[TBL] [Abstract][Full Text] [Related]
35. MmuPV1-Induced Cutaneous Squamous Cell Carcinoma Arises Preferentially from Lgr5+ Epithelial Progenitor Cells.
Moreno R; Buehler D; Lambert PF
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016373
[TBL] [Abstract][Full Text] [Related]
36. Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis.
Elson DA; Riley RR; Lacey A; Thordarson G; Talamantes FJ; Arbeit JM
Cancer Res; 2000 Mar; 60(5):1267-75. PubMed ID: 10728686
[TBL] [Abstract][Full Text] [Related]
37. Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice.
Arbeit JM; Howley PM; Hanahan D
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2930-5. PubMed ID: 8610145
[TBL] [Abstract][Full Text] [Related]
38. Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model.
Brake T; Lambert PF
Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2490-5. PubMed ID: 15699322
[TBL] [Abstract][Full Text] [Related]
39. T cell-mediated antitumor immune response eliminates skin tumors induced by mouse papillomavirus, MmuPV1.
Joh J; Chilton PM; Wilcher SA; Zahin M; Park J; Proctor ML; Ghim SJ; Jenson AB
Exp Mol Pathol; 2017 Oct; 103(2):181-190. PubMed ID: 28939161
[TBL] [Abstract][Full Text] [Related]
40. Immunity to commensal papillomaviruses protects against skin cancer.
Strickley JD; Messerschmidt JL; Awad ME; Li T; Hasegawa T; Ha DT; Nabeta HW; Bevins PA; Ngo KH; Asgari MM; Nazarian RM; Neel VA; Jenson AB; Joh J; Demehri S
Nature; 2019 Nov; 575(7783):519-522. PubMed ID: 31666702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
